Destination Europe:Research and Innovation Opportunities

Gitte Neubauer, Founder and VP Research Operations, Cellzome

A European career: the academic part

Vocational training Work A-levels Work in UK Start of Undergraduate Studies in Biochemistry PhD in Proteomics

Imperial College, London (Natural Sciences)

>1,200 staff / 3,000 undergraduates /1,200 postgraduate students

natural sciences embedded with medical faculty and hospitals / translation of research

European Molecular Biology Laboratory, Heidelberg, Germany

>1,500 staff / >70 nationalities / 4 outstations

EMBL ranks no. 4 world-wide (after CSH, MIT, Salk) institute in molecular biology & genetics*

>2000 collaborations world-wide2*1999-2009, Thomson Essential Science Indicators

Located in Heidelberg, an international city in the middle of Europe

A European career: the industry part

› Foundation of Cellzome in 2000

› Started as proteomics platform and is now a drug discovery company

› World-leading chemoproteomics platform

› Financing through early venture capital and since 2004 through collaborations with big pharma

3

2000

2011

2002Nature

2004Nat Cell Bio

2006Nature

2007Nat Biotech

2007Nat Biotech

2009Nature

2011Nat Biotech

2011Nature

› Addition of skill sets for drug discovery while retaining

› International culture

› High quality

› Open, respectful, collaborrative culture

Industry or academia - family or career? – Take the best of all worlds!

› Many moves from academia to industry and back:

› 9 Cellzomers are now professors/groupleaders in academia

› Many moves from biotech to pharma:

› 10 people moved to big pharma

› Women careers: family or career?

› Higher availability of day care facilities for small kids and (even in Germany) more all day schools

› First men take time off with their kids – perception is changing

› Technology allows work from home more effectively

› Not the case for lab-based positions

› But: still few women in pharma or biotech senior management

4